SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001420720-22-000030
Filing Date
2022-05-13
Accepted
2022-05-13 09:33:19
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A ibio-20220512xdefa14a.htm DEFA14A 53678
2 EX-3.1 ibio-20220512xex3d1.htm EX-3.1 73062
3 EX-10.1 ibio-20220512xex10d1.htm EX-10.1 104216
4 EX-10.2 ibio-20220512xex10d2.htm EX-10.2 13325
  Complete submission text file 0001420720-22-000030.txt   245436
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-35023 | Film No.: 22920617
SIC: 2834 Pharmaceutical Preparations